Europe Tinnitus Drug Market Research Report Forecast 2017-2021

May 2017 | 132 pages | ID: E073856865CEN
S&P Consulting

Abstracts

The Europe Tinnitus Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Tinnitus Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tinnitus Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Tinnitus Drug Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer
Actavis
Teva
Mylan
Sun Pharmaceutical
Sandoz
Mallinckrodt
Taro Pharmaceutical
company 9

Europe Tinnitus Drug Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Tinnitus Drug Market Analysis by Application:
Hospital
Clinics
Homecare

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 TINNITUS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Tinnitus Drug
1.2 Classification of Tinnitus Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Tinnitus Drug
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Homecare
1.4 Tinnitus Drug Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Tinnitus Drug (2012-2021)
  1.5.1 Europe Tinnitus Drug Sales and Growth Rate (2012-2021)
  1.5.2 Europe Tinnitus Drug Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON TINNITUS DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 TINNITUS DRUG MANUFACTURING COST ANALYSIS

3.1 Tinnitus Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Tinnitus Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Tinnitus Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Tinnitus Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE TINNITUS DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Tinnitus Drug Market Competition by Manufacturers
  5.1.1 Europe Tinnitus Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Tinnitus Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Tinnitus Drug (Volume and Value) by Type
  5.2.1 Europe Tinnitus Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Tinnitus Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Tinnitus Drug (Volume and Value) by Countries
  5.3.1 Europe Tinnitus Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Tinnitus Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Tinnitus Drug (Volume) by Application

6 GERMANY TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Tinnitus Drug Sales and Value (2012-2017)
  6.1.1 Germany Tinnitus Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Tinnitus Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Tinnitus Drug Sales Price Trend (2012-2017)
6.2 Germany Tinnitus Drug Sales and Market Share by Manufacturers
6.3 Germany Tinnitus Drug Sales and Market Share by Type
6.4 Germany Tinnitus Drug Sales and Market Share by Application

7 FRANCE TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Tinnitus Drug Sales and Value (2012-2017)
  7.1.1 France Tinnitus Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Tinnitus Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Tinnitus Drug Sales Price Trend (2012-2017)
7.2 France Tinnitus Drug Sales and Market Share by Manufacturers
7.3 France Tinnitus Drug Sales and Market Share by Type
7.4 France Tinnitus Drug Sales and Market Share by Application

8 UK TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Tinnitus Drug Sales and Value (2012-2017)
  8.1.1 UK Tinnitus Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Tinnitus Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Tinnitus Drug Sales Price Trend (2012-2017)
8.2 UK Tinnitus Drug Sales and Market Share by Manufacturers
8.3 UK Tinnitus Drug Sales and Market Share by Type
8.4 UK Tinnitus Drug Sales and Market Share by Application

9 RUSSIA TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Tinnitus Drug Sales and Value (2012-2017)
  9.1.1 Russia Tinnitus Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Tinnitus Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Tinnitus Drug Sales Price Trend (2012-2017)
9.2 Russia Tinnitus Drug Sales and Market Share by Manufacturers
9.3 Russia Tinnitus Drug Sales and Market Share by Type
9.4 Russia Tinnitus Drug Sales and Market Share by Application

10 ITALY TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Tinnitus Drug Sales and Value (2012-2017)
  10.1.1 Italy Tinnitus Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Tinnitus Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Tinnitus Drug Sales Price Trend (2012-2017)
10.2 Italy Tinnitus Drug Sales and Market Share by Manufacturers
10.3 Italy Tinnitus Drug Sales and Market Share by Type
10.4 Italy Tinnitus Drug Sales and Market Share by Application

11 SPAIN TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Tinnitus Drug Sales and Value (2012-2017)
  11.1.1 Spain Tinnitus Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Tinnitus Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Tinnitus Drug Sales Price Trend (2012-2017)
11.2 Spain Tinnitus Drug Sales and Market Share by Manufacturers
11.3 Spain Tinnitus Drug Sales and Market Share by Type
11.4 Spain Tinnitus Drug Sales and Market Share by Application

12 BENELUX TINNITUS DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Tinnitus Drug Sales and Value (2012-2017)
  12.1.1 Benelux Tinnitus Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Tinnitus Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Tinnitus Drug Sales Price Trend (2012-2017)
12.2 Benelux Tinnitus Drug Sales and Market Share by Manufacturers
12.3 Benelux Tinnitus Drug Sales and Market Share by Type
12.4 Benelux Tinnitus Drug Sales and Market Share by Application

13 EUROPE TINNITUS DRUG MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Actavis
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Teva
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Mylan
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Sun Pharmaceutical
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Sandoz
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Mallinckrodt
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Taro Pharmaceutical
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 company
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE TINNITUS DRUG MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Tinnitus Drug Market Forecast by Type (2017-2021)
15.9 Europe Tinnitus Drug Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tinnitus Drug
Table Classification of Tinnitus Drug
Figure Europe Sales Market Share of Tinnitus Drug by Type in 2015
Table Application of Tinnitus Drug
Figure Europe Sales Market Share of Tinnitus Drug by Application in 2015
Figure Germany Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure France Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure UK Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure Russia Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure Italy Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure Spain Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure Benelux Tinnitus Drug Revenue and Growth Rate (2012-2021)
Figure Europe Tinnitus Drug Sales and Growth Rate (2012-2021)
Figure Europe Tinnitus Drug Revenue and Growth Rate (2012-2021)
Table Europe Tinnitus Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Tinnitus Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Tinnitus Drug Sales Share by Manufacturers
Figure 2016 Tinnitus Drug Sales Share by Manufacturers
Table Europe Tinnitus Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Tinnitus Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Tinnitus Drug Revenue Share by Manufacturers
Table 2016 Europe Tinnitus Drug Revenue Share by Manufacturers
Table Europe Tinnitus Drug Sales and Market Share by Type (2012-2017)
Table Europe Tinnitus Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Tinnitus Drug by Type (2012-2017)
Figure Europe Tinnitus Drug Sales Growth Rate by Type (2012-2017)
Table Europe Tinnitus Drug Revenue and Market Share by Type (2012-2017)
Table Europe Tinnitus Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Tinnitus Drug by Type (2012-2017)
Figure Europe Tinnitus Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Tinnitus Drug Sales and Market Share by Countries (2012-2017)
Table Europe Tinnitus Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Tinnitus Drug by Countries (2012-2017)
Table Europe Tinnitus Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Tinnitus Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Tinnitus Drug by Countries (2012-2017)
Table Europe Tinnitus Drug Sales and Market Share by Application (2012-2017)
Table Europe Tinnitus Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Tinnitus Drug by Application (2012-2017)
Figure Germany Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure Germany Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure Germany Tinnitus Drug Sales Price Trend (2012-2017)
Table Germany Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table Germany Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Tinnitus Drug Sales by Type (2015 and 2016)
Table Germany Tinnitus Drug Market Share by Type (2015 and 2016)
Table Germany Tinnitus Drug Sales by Application (2015 and 2016)
Table Germany Tinnitus Drug Market Share by Application (2015 and 2016)
Figure France Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure France Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure France Tinnitus Drug Sales Price Trend (2012-2017)
Table France Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table France Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table France Tinnitus Drug Sales by Type (2015 and 2016)
Table France Tinnitus Drug Market Share by Type (2015 and 2016)
Table France Tinnitus Drug Sales by Application (2015 and 2016)
Table France Tinnitus Drug Market Share by Application (2015 and 2016)
Figure UK Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure UK Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure UK Tinnitus Drug Sales Price Trend (2012-2017)
Table UK Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table UK Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table UK Tinnitus Drug Sales by Type (2015 and 2016)
Table UK Tinnitus Drug Market Share by Type (2015 and 2016)
Table UK Tinnitus Drug Sales by Application (2015 and 2016)
Table UK Tinnitus Drug Market Share by Application (2015 and 2016)
Figure Russia Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure Russia Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure Russia Tinnitus Drug Sales Price Trend (2012-2017)
Table Russia Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table Russia Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Tinnitus Drug Sales by Type (2015 and 2016)
Table Russia Tinnitus Drug Market Share by Type (2015 and 2016)
Table Russia Tinnitus Drug Sales by Application (2015 and 2016)
Table Russia Tinnitus Drug Market Share by Application (2015 and 2016)
Figure Italy Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure Italy Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure Italy Tinnitus Drug Sales Price Trend (2012-2017)
Table Italy Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table Italy Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Tinnitus Drug Sales by Type (2015 and 2016)
Table Italy Tinnitus Drug Market Share by Type (2015 and 2016)
Table Italy Tinnitus Drug Sales by Application (2015 and 2016)
Table Italy Tinnitus Drug Market Share by Application (2015 and 2016)
Figure Spain Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure Spain Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure Spain Tinnitus Drug Sales Price Trend (2012-2017)
Table Spain Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table Spain Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Tinnitus Drug Sales by Type (2015 and 2016)
Table Spain Tinnitus Drug Market Share by Type (2015 and 2016)
Table Spain Tinnitus Drug Sales by Application (2015 and 2016)
Table Spain Tinnitus Drug Market Share by Application (2015 and 2016)
Figure Benelux Tinnitus Drug Sales and Growth Rate (2012-2017)
Figure Benelux Tinnitus Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Tinnitus Drug Sales Price Trend (2012-2017)
Table Benelux Tinnitus Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Tinnitus Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Tinnitus Drug Sales by Type (2015 and 2016)
Table Benelux Tinnitus Drug Market Share by Type (2015 and 2016)
Table Benelux Tinnitus Drug Sales by Application (2015 and 2016)
Table Benelux Tinnitus Drug Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Tinnitus Drug Sales Market Share (2012-2017)
Table Actavis Basic Information List
Table Actavis Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Actavis Tinnitus Drug Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Tinnitus Drug Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Tinnitus Drug Sales Market Share (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Tinnitus Drug Sales Market Share (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sandoz Tinnitus Drug Sales Market Share (2012-2017)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mallinckrodt Tinnitus Drug Sales Market Share (2012-2017)
Table Taro Pharmaceutical Basic Information List
Table Taro Pharmaceutical Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Taro Pharmaceutical Tinnitus Drug Sales Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Tinnitus Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Tinnitus Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tinnitus Drug
Figure Manufacturing Process Analysis of Tinnitus Drug
Figure Tinnitus Drug Industrial Chain Analysis
Table Raw Materials Sources of Tinnitus Drug Major Manufacturers in 2015
Table Major Buyers of Tinnitus Drug
Table Distributors/Traders List
Figure Germany Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure Germany Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure France Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure France Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure UK Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure UK Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure Russia Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure Italy Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure Spain Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Tinnitus Drug Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Tinnitus Drug Revenue and Growth Rate Forecast (2017-2021)
Table Europe Tinnitus Drug Sales Forecast by Type (2017-2021)
Table Europe Tinnitus Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Pfizer
Actavis
Teva
Mylan
Sun Pharmaceutical
Sandoz
Mallinckrodt
Taro Pharmaceutical